| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 04/10/2014 | WO2014054391A1 Compound, method for producing said compound, method for producing acetate derivative, method for producing atorvastatin, and method for collecting asymmetric ligand |
| 04/10/2014 | WO2014053210A1 Pyrrolidines |
| 04/10/2014 | US20140100375 Novel crystalline form of atorvastatin hemi-calcium salt, hydrate thereof, and method of producing the same |
| 04/10/2014 | US20140100227 C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof |
| 04/10/2014 | US20140100211 New pyrrolidine derivatives, pharmaceutical compositions and uses thereof |
| 04/10/2014 | US20140099333 Pyrrolidinone derivatives as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders |
| 04/09/2014 | EP2716629A1 Method for producing optically active alpha-substituted proline |
| 04/09/2014 | EP2716625A1 Cinnamic acid derivative, polymer thereof, and liquid crystal alignment layer comprising cured article thereof |
| 04/09/2014 | EP2714685A1 Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives |
| 04/09/2014 | EP2714684A1 Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives |
| 04/09/2014 | EP2714027A1 Fatty acid amide hydrolase inhibitors for treating pain |
| 04/09/2014 | CN103717595A Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives |
| 04/09/2014 | CN103717219A Left ventricular diastolic function improving agent |
| 04/09/2014 | CN103709087A Preparation method of alpha-pyrrolidone |
| 04/09/2014 | CN103709032A Preparation method of dibutyl carbonate through catalyzed synthesis of proline ionic liquid |
| 04/09/2014 | CN102698803B Ruthenium complex catalyst and preparation method and application thereof |
| 04/09/2014 | CN102548965B Substituted amide compound |
| 04/09/2014 | CN102219765B Method for synthesizing chloro(bromo)alkenyl cyclocompound with iron catalyst alkynyl acetal |
| 04/09/2014 | CN102089280B Polymerizable optically active imide compound and polymerizable composition containing compound |
| 04/09/2014 | CN102026961B 酰胺化合物 Amide compounds |
| 04/08/2014 | US8692002 Synthetic process for aminocyclohexyl ether compounds |
| 04/08/2014 | US8691977 Certain chemical entities, compositions, and methods |
| 04/08/2014 | US8691861 Prodrugs of inhibitors of plasma kallikrein |
| 04/08/2014 | US8691848 Inhibitors of caspases |
| 04/08/2014 | US8691816 Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents |
| 04/08/2014 | US8691710 Group IV metal complexes for metal-containing film deposition |
| 04/08/2014 | CA2780040C 4r,5s-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity |
| 04/08/2014 | CA2527069C Polyaspartimides |
| 04/03/2014 | WO2014051445A1 Pyrrole-3,4-dicarboxamides |
| 04/03/2014 | WO2014048958A1 Process for the preparation of optionally substituted phenyl and pyridyl pyrrolidines |
| 04/03/2014 | WO2014048692A1 Low catalyst loading in metathesis reactions |
| 04/03/2014 | WO2014048165A1 Compound as potassium channel modulator |
| 04/03/2014 | US20140094615 Automated Synthesis of Small Molecules Using Chiral, Non-Racemic Boronates |
| 04/03/2014 | US20140094495 Antimicrobial Haloalkyl Heterocycle Compounds |
| 04/03/2014 | US20140094399 Biodegradable poly(beta-amino esters) and uses thereof |
| 04/03/2014 | US20140093513 Methods of lowering proprotein conversate subtilisin/kexin type 9 (pcsk9) |
| 04/03/2014 | US20140093450 Pretargeting kit for imaging or therapy comprising a trans-cyclooctene dienophile and a diene |
| 04/02/2014 | CN103702996A Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives |
| 04/02/2014 | CN103702982A Micronized crystals of atorvastatin hemicalcium |
| 04/02/2014 | CN103702981A Method for producing optically active 2-methylproline derivative |
| 04/02/2014 | CN103702980A Cyclic amine derivatives as EP4 receptor antagonists |
| 04/02/2014 | CN103694163A Compounds capable of being adopted as potassium channel modulators |
| 04/02/2014 | CN103694159A Preparation method of (S)-4-hydroxy-2-oxo-1-pyrrolidineacetamide |
| 04/02/2014 | CN103694158A 2,3-disubstituted-4,5-dihydro-3-trifluoromethyl pyrrolin trifluoromethanesulfonate, and preparation method and application thereof |
| 04/02/2014 | CN102827895B Double-liquid-phase fermentation method of coupling in-situ extraction antrodia camphorate active product antrondin C |
| 04/01/2014 | US8686163 Process for forming amorphous atorvastatin |
| 04/01/2014 | US8686162 Maleimide-functional monomers in amorphous form |
| 04/01/2014 | US8686032 Enzyme inhibitors |
| 04/01/2014 | CA2754932C Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) |
| 04/01/2014 | CA2655789C Enantiomerically pure flavone derivatives for the treatment of poliferative disorders and processes for their preparation |
| 04/01/2014 | CA2633958C Compounds and methods for inhibiting the interaction of bcl proteins with binding partners |
| 04/01/2014 | CA2627502C Process for production of benzyloxypyrrolidine derivative, and process for production of hydrochloride salt powder of optically active benzyloxypyrrolidine derivative |
| 04/01/2014 | CA2594098C Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 03/27/2014 | WO2014047020A1 Dihydropyrrolidino-pyrimidines as kinase inhibitors |
| 03/27/2014 | WO2014046441A1 Dolastatin-10 derivative, method of producing same and anticancer drug composition containing same |
| 03/27/2014 | US20140088308 Fluoride-Releasing Compositions |
| 03/27/2014 | US20140088074 Fluorinated arylalkylaminocarboxamide derivatives |
| 03/26/2014 | EP2711351A1 Low catalyst loading in metathesis reactions |
| 03/26/2014 | EP2709983A1 Insecticidal compounds based on arylthioacetamide derivatives |
| 03/26/2014 | CN103687846A Benzylamine derivatives as inhibitors of plasma kallikrein |
| 03/26/2014 | CN103664896A Synthetic process method for novel antineoplastic molecular targeted drug of crizotinib |
| 03/26/2014 | CN103664877A Quinoline, preparation method and application of quinoline |
| 03/26/2014 | CN103664732A Synthetic method of N-phenylmaleimide |
| 03/26/2014 | CN103664731A Preparation method of 3-(3,4-dimethoxy phenyl)-4-(3,4,5-trimethoxy phenyl)-1H-pyrrole-2,5-dione |
| 03/26/2014 | CN103664730A Method for synthesizing pyrrole derivative based on methylene cyclopropane cycloaddition reaction |
| 03/26/2014 | CN103664729A Method for preparing L-pyroglutamic acid |
| 03/26/2014 | CN103664728A Method for recovering nuclear matrix protein (NMP) solvent in production of lithium ion battery |
| 03/26/2014 | CN103664727A Technology for preparing 1-[(3s)-3-hydroxypyrrolidine-1-base]-(2s)-2-methylamino-2-phenylethane with one-pot method |
| 03/26/2014 | CN103657716A Functionalized ionic liquid synthesis method |
| 03/26/2014 | CN101805280B Preparation method of N,N'-m-phenylenebismaleimide |
| 03/25/2014 | US8680294 Enantio- and stereo specific synthesis of β-amino-α-hydroxy amides |
| 03/25/2014 | US8680127 Fungicide N-cycloalkyl-N-biphenylmethyl-carboxamide derivatives |
| 03/25/2014 | US8680100 Sulfonylhydrazide compounds for treating proliferative disorders |
| 03/25/2014 | US8679773 Kits pertaining to analyte determination |
| 03/25/2014 | CA2379891C Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity |
| 03/20/2014 | WO2014041059A1 Process to produce atorvastatin intermediates |
| 03/20/2014 | WO2014041058A1 Process to produce atorvastatin intermediates |
| 03/20/2014 | US20140081033 Novel Crystalline Form of Atorvastatin Hemi-calcium Salt, Hydrate Thereof, And Method of Producing The Same |
| 03/20/2014 | US20140081019 Process for the preparation of deuterated compounds containing n-alkyl groups |
| 03/20/2014 | US20140081012 Nanoparticle, liposomes, polymers, agents and proteins modified with reversible linkers |
| 03/20/2014 | US20140081010 Processes for the convergent synthesis of calicheamicin derivatives |
| 03/20/2014 | US20140080833 Intracellular kinase inhibitors |
| 03/20/2014 | US20140080780 identification of compounds that disperse tdp-43 inclusions |
| 03/20/2014 | US20140080770 Arylalkylamine compound and process for preparing the same |
| 03/19/2014 | CN103649047A Novel processes for the preparation of prostaglandin amides |
| 03/19/2014 | CN103642000A Curing agent, preparation method of curing agent and epoxy resin adhesive |
| 03/19/2014 | CN103641764A Pharmaceutical composition for regulating blood lipid |
| 03/19/2014 | CN103641763A Procede de preparation de derives de porphyrine, telle que la protoporphyrine (ix) et intermediaire de synthese |
| 03/19/2014 | CN103641762A Transient receptor potential vanilloid 1/epoxidase 2(TRPV1/COX-2) dual inhibitor, and preparation method and application thereof in preparation of analgesic medicament |
| 03/19/2014 | CN103641761A Vildagliptin preparation method |
| 03/19/2014 | CN102887851B Compound 3,5-dimethyl-1H-pyrrole-2,4-diformaldehyde and preparation method thereof |
| 03/19/2014 | CN102627518B Preparation method of N-nitrosamine |
| 03/19/2014 | CN102432474B Preparation method of high-purity alkylammonium tetrafluoroborate for super capacitor |
| 03/19/2014 | CN101454309B Synthesis and uses of pyroglutamic acid derivatives |
| 03/18/2014 | US8674135 Functionalized ionic liquids, and methods of use thereof |
| 03/18/2014 | US8674115 CRTH2 modulators |
| 03/18/2014 | US8673962 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission |
| 03/18/2014 | US8673961 Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents |
| 03/18/2014 | US8673904 Epoxide inhibitors of cysteine proteases |
| 03/18/2014 | US8673903 Substituted 8-alkoxy-2-aminotetralin derivatives, and use thereof |